Author: Fang, Hengsheng; Wegman, Adam D.; Ripich, Kianna; Friberg, Heather; Currier, Jeffrey R.; Thomas, Stephen J.; Endy, Timothy P.; Waickman, Adam T.
Title: Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity Cord-id: q2l8suan Document date: 2021_5_15
ID: q2l8suan
Snippet: SARS-CoV-2 represents an unprecedented public health challenge. While the majority of SARS-CoV-2-infected individuals with mild-to-moderate COVID-19 resolve their infection with few complications, some individuals experience prolonged symptoms lasting for weeks after initial diagnosis. Persistent viral infections are commonly accompanied by immunologic dysregulation, but it is unclear if persistent COVID-19 impacts the development of virus-specific cellular immunity. To this end, we analyzed SAR
Document: SARS-CoV-2 represents an unprecedented public health challenge. While the majority of SARS-CoV-2-infected individuals with mild-to-moderate COVID-19 resolve their infection with few complications, some individuals experience prolonged symptoms lasting for weeks after initial diagnosis. Persistent viral infections are commonly accompanied by immunologic dysregulation, but it is unclear if persistent COVID-19 impacts the development of virus-specific cellular immunity. To this end, we analyzed SARS-CoV-2-specific cellular immunity in convalescent COVID-19 patients who experienced eight days or fewer of COVID-19 symptoms or symptoms persisting for 18 days or more. We observed that persistent COVID-19 symptoms were not associated with the development of an overtly dysregulated cellular immune response. Furthermore, we observed that reactivity against the N protein from SARS-CoV-2 correlates with the amount of reactivity against the seasonal human coronaviruses 229E and NL63. These results provide insight into the processes that regulate the development of cellular immunity against SARS-CoV-2 and related human coronaviruses.
Search related documents:
Co phrase search for related documents- activation marker and acute sars infection: 1, 2, 3, 4
- activity impact and acute illness: 1
- activity impact and acute infection: 1, 2
- activity impact and acute sars infection: 1, 2
- activity impact and acute symptom: 1
- activity impact and long period: 1, 2
- activity impact and long short: 1, 2, 3, 4, 5, 6, 7, 8
- acute illness and long duration: 1, 2
- acute illness and long period: 1, 2
- acute illness and long short: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute infection and long duration: 1, 2, 3, 4
- acute infection and long period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute infection and long short: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute sars infection and long duration: 1
- acute sars infection and long period: 1, 2, 3, 4
- acute sars infection and long short: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute symptom and long period: 1
- acute symptom and long short: 1
Co phrase search for related documents, hyperlinks ordered by date